Downregulation of VEGF-D expression by interleukin-1β in cardiac microvascular endothelial cells is mediated by MAPKs and PKCα/ β1

Journal of Cellular Physiology

Volumn 215, Issue 2, 2008, Pages 337-343

  Mountain, Deidra J H ^a   Singh, Mahipal ^a   Singh, Krishna ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; BETA CATENIN; COMPLEMENTARY DNA; GLYCOGEN SYNTHASE KINASE 3; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; GLYCOGEN SYNTHASE KINASE 3 BETA; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME INHIBITION; GENE EXPRESSION; HEART MUSCLE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CORONARY BLOOD VESSEL; DOSE RESPONSE; DRUG EFFECT; GENETICS; METABOLISM; MICROCIRCULATION;

RATTUS;

ANIMALS; CELLS, CULTURED; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENDOTHELIAL CELLS; GENE EXPRESSION; GLYCOGEN SYNTHASE KINASE 3; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICROCIRCULATION; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 40949117155     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21315     Document Type: Article

References (45)

1. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA. 1998. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95:548-553.
2. Arend WP, Dayer JM. 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 38:151-160.
3. Byzova TV, Goldman CK, Jankau J, Chen J, Cabrera G, Achen MG, Stacker SA, Carnevale KA, Siemionow M, Deitcher SR, DiCorleto PE. 2002. Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Blood 99:4434-4442.
4. Chaudhary LR, Avioli LV. 2000. Extracellular-signal regulated kinase signaling pathway mediates down regulation of type 1 procollagen gene expression by FGF-2, PDGF-BB, and okadaic acid in osteoblastic cells. J Cell Biochem 76:354-359.
5. Clerk A, Sugden PH. 2001. Untangling the Web: Specific signaling from PKC isoforms to MAPK cascades. Circ Res 89:847-849.
6. Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y, Pan Y, Li Z, Bargou RC, Qin J, Lai CC, Tsai FJ, Tsai CH, Hung MC. 2005. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol Cell 19:159-170.
7. Ferrara N. 1996. Vascular endothelial growth factor. Eur J Cancer 32A:2413-2422.
8. Finkenzeller G, Marme D, Weich HA, Hug H. 1992. Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Res 52:4821-4823.
9. Heidkamp MC, Bayer AL, Martin JL, Samarel AM. 2001. Differential activation of mitogen-activated protein kinase cascades and apoptosis by protein kinase C epsilon and delta in neonatal rat ventricular myocytes. Circ Res 89:882-890.
10. Heidkamp MC, Scully BT, Vijayan K, Engman SJ, Szotek EL, Samarel AM. 2005. PYK2 regulates SERCA2 gene expression in neonatal rat ventricular myocytes. Am J Physiol Cell Physiol 289:C471-C482.
11. Henderson BR, Fagotto F. 2002. The ins and outs of APC and beta-catenin nuclear transport. EMBO Rep 3:834-839.
12. Hwang MW, Matsumori A, Furukawa Y, Ono K, Okada M, Iwasaki A, Hara M, Miyamoto T, Touma M, Sasayama S. 2001. Neutralization of interleukin-1beta in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling. J Am Coll Cardiol 38:1546-1553.
13. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M, Alitalo K. 1995. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92:3566-3570.
14. Kawata H, Yoshida K, Kawamoto A, Kurioka H, Takase E, Sasaki Y, Hatanaka K, Kobayashi M, Ueyama T, Hashimoto T, Dohi K. 2001. Ischemic preconditioning upregulates vascular endothelial growth factor mRNA expression and neovascularization via nuclear translocation of protein kinase C epsilon in the rat ischemic myocardium. Circ Res 88:696-704.
15. Kim CW, Suh SI, Sung SH, Lee IK, Lee KS. 2005. A transcriptional factor decoy against AP-1 suppresses TGF-beta1-induced type 1 collagen gene expression in cultured keloid fibroblasts. J Dermatol Sci 37:49-51.
16. Li J, Perrella MA, Tsai JC, Yet SF, Hsieh CM, Yoshizumi M, Patterson C, Endege WO, Zhou F, Lee ME. 1995. Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. J Biol Chem 270:308-312.
17. Martiny-Baron G, Kazaniecz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C. 1993. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268:9194-9197.
18. Maruyama K, Mori Y, Murasawa S, Masaki H, Takahashi N, Tsutusmi Y, Moriguchi Y, Shibazaki Y, Tanaka Y, Shibuya M, Inada M, Matsubara H, Iwasaka T. 1999. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases. J Mol Cell Cardiol 31:607-617.
19. Mifflin RC, Saada JI, Di Mari JF, Adegboyega PA, Valentich JD, Powell DW. 2002. Regulation of COX-2 expression in human intestinal myofibroblasts: Mechanisms of IL-1-mediated induction. Am J Physiol Cell Physiol 282:C824-C834.
20. Milanini J, Vinals F, Pouyssegur J, Pages G. 1998. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J Biol Chem 273:18165-18172.
21. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A. 1993. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846.
22. Mountain DJ, Singh M, Menon B, Singh K. 2007. Interleukin-1{beta} increases expression and activity of matrix metalloproteinase-2 in cardiac microvascular endothelial cells: Role of PKC{alpha}/{beta}1 and MAPKs. Am J Physiol Cell Physiol 292:C867-C875.
23. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S. 1998. Cytokine gene expression after myocardial infarction in rat hearts: Possible implication in left ventricular remodeling. Circulation 98:149-156.
24. Orlandini M, Marconcini L, Ferruzzi R, Oliviero S. 1996. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA 93:11675-11680.
25. Orlandini M, Semboloni S, Oliviero S. 2003. Beta-catenin inversely regulates vascular endothelial growth factor-D mRNA stability. J Biol Chem 278:44650-44656.
26. Polakis P. 2000. Wnt signaling and cancer. Genes Dev 14:1837-1851.
27. Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen Ml, Kholova I, Kauppinen RA, Achen MG, Stacker SA, Alitalo K, Yla-Herttuala S. 2003. VEGF-D is the strongest angiogenic and lymph angiogenic effector among VEGFs delivered into skeleca' muscle via adenoviruses. Circ Res 92:1098-1106.
28. Ristimaki A, Narko K, Enholm B, Joukov V, Alitalo K. 1998. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273:8413-8418.
29. Rocchigiani M, Lestingi M, Luddi A, Orlandini M, Franco B, Rossi E, Ballabio A, Zuffardi O, Oliviero S. 1998. Human FIGF: Cloning, gene structure, and mapping to chromosome Xp22.1 between the PIGA and the GRPR genes. Genomics 47:207-216.
30. Rutanen J, Rissanen TT, Markkanen JE, Gruchala M, Silvennoinen P, Kivela A, Hedman A, Hedman M, Heikura T, Orden MR, Stacker SA, Achen MG, Hartikainen J, Yla-Herttuafa S. 2004. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 109:1029-1035.
31. Soucy NV, Klei LR, Mayka DD, Barchowsky A. 2004, Signaling pathways for arsenic-stimulated vascular endothelial growth factor-a expression in primary vascular smooth muscle cells. Chem Res Toxicol 17:555-563.
32. Stacker SA, Stenvers K, Caesar C, Vitali A, Domagala T, Nice E, Roufail S, Simpson RJ, Moritz R, Karpanen T, Alitalo K, Achen MG. 1999. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem 274:32127-32136.
33. Sutherland C, Leighton IA, Cohen P. 1993. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: New kinase connections in insulin and growth-factor signalling. Biochem J 296:15-19.
34. Suzuki K, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y, Yacoub MH. 2001. Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 104:1308-1313.
35. Tanaka T, Kanai H, Sekiguchi K, Aihara Y, Yokoyama T, Arai M, Kanda T, Nagai R, Kurabayashi M. 2000. Induction of VEGF gene transcription by IL-1 beta is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes. J Mol Cell Cardiol 32:1955-1967.
36. Ukimura A, Terasaki F, Fujioka S, Deguchi H, Kitaura Y, Isomura T, Suma H. 2003. Quantitative analysis of cytokine mRNA expression in hearts from patients with nonischemic dilated cardiomyopathy (DCM). J Card Surg 18 (Suppl 2): S101-S108.
37. Vines A, Cahoon S, Goldberg I, Saxena U, Pillarisetti S. 2006. Novel anti-inflammatory role for glycogen synthase kinase-3beta in the inhibition of tumor necrosis factor-alpha- and interleukin-1 beta-induced inflammatory gene expression. J Biol Chem 281:16985-16990.
38. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA, Apte RN. 2003. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 100:2645-2650.
39. Wang Q, Zhou Y, Wang X, Evers BM. 2006. Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase. Oncogene 25:43-50.
40. Wu G, Mannam AP, Wu J, Kirbis S, Shie JL, Chen C, Laham RJ, Sellke FW, Li J. 2003. Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: Role of VEGF. Am J Physiol Heart Circ Physiol 285:H2420-H2429.
41. Xie Z, Pimental DR, Lohan S, Vasertriger A, Pligavko C, Colucci WS, Singh K. 2001. Regulation of angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells: Role of p42/44 mitogen-activated protein kinase and reactive oxygen species. J Cell Physiol 188:132-138.
42. Xie Z, Singh M, Singh K. 2004a. Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta. J Biol Chem 279:39513-39519.
43. Xie Z, Singh M, Singh K. 2004b. ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species-mediated induction of osteopontin gene expression by angiotensin II and interleukin-1beta in adult rat cardiac fibroblasts. J Cell Physiol 198:399-407.
44. Yoon S, Seger R. 2006. The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions. Growth Factors 24:21-44.
45. Yue P, Massie BM, Simpson PC, Long CS. 1998. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol 275:H250-H258.